Pulmonx Corporation is a medical devices business based in the US. Pulmonx Corporation shares (LUNG) are listed on the NASDAQ and all prices are listed in US Dollars. Pulmonx Corporation employs 220 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Pulmonx Corporation
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LUNG – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Pulmonx Corporation stock price (NASDAQ: LUNG)Use our graph to track the performance of LUNG stocks over time.
Pulmonx Corporation shares at a glance
|Latest market close||$39.54|
|52-week range||$35.81 - $69.48|
|50-day moving average||$38.92|
|200-day moving average||$41.25|
|Wall St. target price||$55.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.39|
Buy Pulmonx Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Pulmonx Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Pulmonx Corporation price performance over time
|1 week (2021-10-15)||-0.68%|
|1 month (2021-09-23)||-0.18%|
|3 months (2021-07-23)||-1.64%|
|6 months (2021-04-23)||-12.07%|
|1 year (2020-10-23)||-6.39%|
|2 years (2019-10-19)||N/A|
|3 years (2018-10-19)||N/A|
|5 years (2016-10-19)||N/A|
Pulmonx Corporation financials
|Revenue TTM||$41.9 million|
|Gross profit TTM||$21.2 million|
|Return on assets TTM||-15.38%|
|Return on equity TTM||-35.49%|
|Market capitalisation||$1.5 billion|
TTM: trailing 12 months
Shorting Pulmonx Corporation shares
There are currently 1.4 million Pulmonx Corporation shares held short by investors – that's known as Pulmonx Corporation's "short interest". This figure is 20.9% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting Pulmonx Corporation shares can be evaluated.
Pulmonx Corporation's "short interest ratio" (SIR)
Pulmonx Corporation's "short interest ratio" (SIR) is the quantity of Pulmonx Corporation shares currently shorted divided by the average quantity of Pulmonx Corporation shares traded daily (recently around 369204.85933504). Pulmonx Corporation's SIR currently stands at 3.91. In other words for every 100,000 Pulmonx Corporation shares traded daily on the market, roughly 3910 shares are currently held short.
To gain some more context, you can compare Pulmonx Corporation's short interest ratio against those of similar companies.
However Pulmonx Corporation's short interest can also be evaluated against the total number of Pulmonx Corporation shares, or, against the total number of tradable Pulmonx Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pulmonx Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Pulmonx Corporation shares in existence, roughly 40 shares are currently held short) or 0.046% of the tradable shares (for every 100,000 tradable Pulmonx Corporation shares, roughly 46 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Pulmonx Corporation.
Find out more about how you can short Pulmonx Corporation stock.
Pulmonx Corporation share dividends
We're not expecting Pulmonx Corporation to pay a dividend over the next 12 months.
You may also wish to consider:
- ResMed (RMD.US) (0.62% forward annual dividend yield)
Pulmonx Corporation overview
Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. .
Pulmonx Corporation in the news
Can Pulmonx Corporation (LUNG) Climb 43% to Reach the Level Wall Street Analysts Expect?
Frequently asked questionsWhat percentage of Pulmonx Corporation is owned by insiders or institutions?
Currently 8.478% of Pulmonx Corporation shares are held by insiders and 78.207% by institutions. How many people work for Pulmonx Corporation?
Latest data suggests 220 work at Pulmonx Corporation. When does the fiscal year end for Pulmonx Corporation?
Pulmonx Corporation's fiscal year ends in December. Where is Pulmonx Corporation based?
Pulmonx Corporation's address is: 700 Chesapeake Drive, Redwood City, CA, United States, 94063 What is Pulmonx Corporation's ISIN number?
Pulmonx Corporation's international securities identification number is: US7458481014
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert